title: A call for formal telemedicine training during stroke fellowship.
abstract: During the 20 years since US Food and Drug Administration approval of IV tissue plasminogen activator for acute ischemic stroke, vascular neurology consultation via telemedicine has contributed to an increased frequency of IV tissue plasminogen activator administration and broadened geographic access to the drug. Nevertheless, a growing demand for acute stroke coverage persists, with the greatest disparity found in rural communities underserved by neurologists. To provide efficient and consistent acute care, formal training in telemedicine during neurovascular fellowship is warranted. Herein, we describe our experiences incorporating telestroke into the vascular neurology fellowship curriculum and propose recommendations on integrating formal telemedicine training into the Accreditation Council for Graduate Medical Education vascular neurology fellowship.
authors.affiliation: From The University of Texas Health Science Center at Houston, TX. amanda.l.jagolino@uth.tmc.edu.
authors.forename: Amanda L
authors.initials: AL
authors.lastname: Jagolino
authors.affiliation: From The University of Texas Health Science Center at Houston, TX.
authors.forename: Judy
authors.initials: J
authors.lastname: Jia
authors.affiliation: From The University of Texas Health Science Center at Houston, TX.
authors.forename: Kasey
authors.initials: K
authors.lastname: Gildersleeve
authors.affiliation: From The University of Texas Health Science Center at Houston, TX.
authors.forename: Christy
authors.initials: C
authors.lastname: Ankrom
authors.affiliation: From The University of Texas Health Science Center at Houston, TX.
authors.forename: Chunyan
authors.initials: C
authors.lastname: Cai
authors.affiliation: From The University of Texas Health Science Center at Houston, TX.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Rahbar
authors.affiliation: From The University of Texas Health Science Center at Houston, TX.
authors.forename: Sean I
authors.initials: SI
authors.lastname: Savitz
authors.affiliation: From The University of Texas Health Science Center at Houston, TX.
authors.forename: Tzu-Ching
authors.initials: TC
authors.lastname: Wu
mesh_terms: D061605:Administration, Intravenous; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D007396:Internship and Residency / Q000379:methods*; D009462:Neurology / Q000193:education*; D020521:Stroke / Q000628:therapy*; D011795:Surveys and Questionnaires; D017216:Telemedicine; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator